Site icon Impactiviti

Impactiviti Daily 033110

I realized yesterday that for those who subscribe to the Impactiviti blog via e-mail, the delivery wasn’t occurring until that day after. A friend showed me how to fix that setting in Feedburner – so the Impactiviti Daily News should be arriving hot and fresh with your morning coffee. If you’re not already subscribed via e-mail, you can do that right here.

*****

TODAY’S NEWS

Jupiter, Crestor, and costs. Hmmmm…. And while we’re on Crestor, the TriLipix combo (Certriad) gets a stall from FDA.

The DNA/Patent dispute gets Funky.

Well, that’s a creepy reversal – drug firm investigates FDA.

RECOMMENDED

Social Media “Listening” Strategies – Impactiviti partners with top providers of social media services for pharma – including “listening” strategy/services, and community design and moderation. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

The latest Impactiviti Connection e-newsletter is up! You can subscribe here.

PLUS

From the thoughtful Sally Church: Listening to Patients about Compliance.

JUST FOR FUN

30 Examples of perfectly timed action photography.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Exit mobile version